BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10627914)

  • 1. Immunology of Graves' ophthalmopathy.
    Heufelder AE; Spitzweg C
    Dev Ophthalmol; 1999; 30():24-38. PubMed ID: 10627914
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
    Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?
    Bahn RS
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):287-96, vi. PubMed ID: 10874530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in the evolution of Graves' ophthalmopathy.
    Natt N; Bahn RS
    Autoimmunity; 1997; 26(2):129-36. PubMed ID: 9546815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.
    Douglas RS; Naik V; Hwang CJ; Afifiyan NF; Gianoukakis AG; Sand D; Kamat S; Smith TJ
    J Immunol; 2008 Oct; 181(8):5768-74. PubMed ID: 18832736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' ophthalmopathy and the TSH receptor.
    Franklyn JA
    Lancet; 1993 Aug; 342(8867):318-9. PubMed ID: 8101579
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of Graves' ophthalmopathy.
    Bahn RS; Heufelder AE
    N Engl J Med; 1993 Nov; 329(20):1468-75. PubMed ID: 8413459
    [No Abstract]   [Full Text] [Related]  

  • 9. New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy.
    Ajjan RA; Weetman AP
    J Endocrinol Invest; 2004 Mar; 27(3):237-45. PubMed ID: 15164999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease.
    Martin A; Nakashima M; Zhou A; Aronson D; Werner AJ; Davies TF
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3361-6. PubMed ID: 9329369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease.
    Heufelder AE; Wenzel BE; Scriba PC
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3733-9. PubMed ID: 8855831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
    Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
    Bahn RS; Dutton CM; Joba W; Heufelder AE
    Thyroid; 1998 Feb; 8(2):193-6. PubMed ID: 9510130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of immunogenic hyperthyroidism and endocrine orbitopathy].
    Heufelder AE; Spitzweg C
    Internist (Berl); 1998 Jun; 39(6):599-606. PubMed ID: 9677517
    [No Abstract]   [Full Text] [Related]  

  • 17. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
    Prabhakar BS; Bahn RS; Smith TJ
    Endocr Rev; 2003 Dec; 24(6):802-35. PubMed ID: 14671007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.
    Bahn RS; Heufelder AE
    Thyroid; 1992; 2(1):89-94. PubMed ID: 1525575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.